BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-486

  1. 14 Posts.
    lightbulb Created with Sketch. 15
    The more i read, particularly of the interview with Vince, the more i realise that this current low share price is an anomoly that we will all regret not taking advantage of (unless you already have)

    The product was successful.

    EVEN if it so happened that permetrex WITHOUT CBD was equally effective in the USA as permetrex WITH CBD, it means that they were BOTH successful, not that they weren't.

    I am increasingly confident they will get approval to head into phase 3 and the share price will soar. What an incredible story of suspense and plot twists this stock has become.

    I'm confident !
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.